These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34124935)

  • 1.
    Cohen S; Chung S
    Bioanalysis; 2021 Jul; 13(13):1071-1081. PubMed ID: 34124935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity risk assessment for biotherapeutics through in vitro detection of CD134 and CD137 on T helper cells.
    Cohen S; Myneni S; Batt A; Guerrero J; Brumm J; Chung S
    MAbs; 2021; 13(1):1898831. PubMed ID: 33729092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secukinumab, a novel anti-IL-17A antibody, shows low immunogenicity potential in human in vitro assays comparable to other marketed biotherapeutics with low clinical immunogenicity.
    Karle A; Spindeldreher S; Kolbinger F
    MAbs; 2016; 8(3):536-50. PubMed ID: 26817498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applying MAPPs Assays to Assess Drug Immunogenicity.
    Karle AC
    Front Immunol; 2020; 11():698. PubMed ID: 32373128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical immunogenicity risk assessment of biotherapeutics using CD4 T cell assays.
    Walsh RE; Nix A; Ackaert C; Mazy A; Schockaert J; Pattyn S; Malherbe L
    Front Immunol; 2024; 15():1406040. PubMed ID: 38863708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell multi-omics reveals dyssynchrony of the innate and adaptive immune system in progressive COVID-19.
    Unterman A; Sumida TS; Nouri N; Yan X; Zhao AY; Gasque V; Schupp JC; Asashima H; Liu Y; Cosme C; Deng W; Chen M; Raredon MSB; Hoehn KB; Wang G; Wang Z; DeIuliis G; Ravindra NG; Li N; Castaldi C; Wong P; Fournier J; Bermejo S; Sharma L; Casanovas-Massana A; Vogels CBF; Wyllie AL; Grubaugh ND; Melillo A; Meng H; Stein Y; Minasyan M; Mohanty S; Ruff WE; Cohen I; Raddassi K; ; Niklason LE; Ko AI; Montgomery RR; Farhadian SF; Iwasaki A; Shaw AC; van Dijk D; Zhao H; Kleinstein SH; Hafler DA; Kaminski N; Dela Cruz CS
    Nat Commun; 2022 Jan; 13(1):440. PubMed ID: 35064122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Bioproducts: Cellular Models to Evaluate the Impact of Therapeutic Antibody Aggregates.
    Nabhan M; Pallardy M; Turbica I
    Front Immunol; 2020; 11():725. PubMed ID: 32431697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches to Mitigate the Unwanted Immunogenicity of Therapeutic Proteins during Drug Development.
    Salazar-Fontana LI; Desai DD; Khan TA; Pillutla RC; Prior S; Ramakrishnan R; Schneider J; Joseph A
    AAPS J; 2017 Mar; 19(2):377-385. PubMed ID: 28083796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of innate APOBEC3G and adaptive AID immune responses in HLA-HIV/SIV immunized SHIV infected macaques.
    Wang Y; Whittall T; Rahman D; Bunnik EM; Vaughan R; Schøller J; Bergmeier LA; Montefiori D; Singh M; Schuitemaker H; Lehner T
    PLoS One; 2012; 7(4):e34433. PubMed ID: 22514633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation.
    Jawa V; Cousens LP; Awwad M; Wakshull E; Kropshofer H; De Groot AS
    Clin Immunol; 2013 Dec; 149(3):534-55. PubMed ID: 24263283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.
    Eller MA; Blom KG; Gonzalez VD; Eller LA; Naluyima P; Laeyendecker O; Quinn TC; Kiwanuka N; Serwadda D; Sewankambo NK; Tasseneetrithep B; Wawer MJ; Gray RH; Marovich MA; Michael NL; de Souza MS; Wabwire-Mangen F; Robb ML; Currier JR; Sandberg JK
    PLoS One; 2011 Apr; 6(4):e18779. PubMed ID: 21526194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidrug Antibody Formation in Oncology: Clinical Relevance and Challenges.
    van Brummelen EM; Ros W; Wolbink G; Beijnen JH; Schellens JH
    Oncologist; 2016 Oct; 21(10):1260-1268. PubMed ID: 27440064
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Walsh RE; Lannan M; Wen Y; Wang X; Moreland CA; Willency J; Knierman MD; Spindler L; Liu L; Zeng W; Rocha GV; Obungu V; Lu J; Kaliyaperumal A; Ferrante A; Siegel R; Malherbe LP
    MAbs; 2020; 12(1):1764829. PubMed ID: 32370596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of human recombinant monoclonal antibodies influences the capacity of dendritic cells to stimulate adaptive T-cell responses in vitro.
    Rombach-Riegraf V; Karle AC; Wolf B; Sordé L; Koepke S; Gottlieb S; Krieg J; Djidja MC; Baban A; Spindeldreher S; Koulov AV; Kiessling A
    PLoS One; 2014; 9(1):e86322. PubMed ID: 24466023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant natural killer T cells: bridging innate and adaptive immunity.
    Van Kaer L; Parekh VV; Wu L
    Cell Tissue Res; 2011 Jan; 343(1):43-55. PubMed ID: 20734065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adaptive immunity].
    Kamradt T; Ferrari-Kühne K
    Dtsch Med Wochenschr; 2011 Aug; 136(33):1678-83. PubMed ID: 21833893
    [No Abstract]   [Full Text] [Related]  

  • 17. Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics.
    Gorovits B; Wakshull E; Pillutla R; Xu Y; Manning MS; Goyal J
    J Immunol Methods; 2014 Jun; 408():1-12. PubMed ID: 24861938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The B-cell antigen receptor integrates adaptive and innate immune signals.
    Otipoby KL; Waisman A; Derudder E; Srinivasan L; Franklin A; Rajewsky K
    Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12145-50. PubMed ID: 26371314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate-like T cells straddle innate and adaptive immunity by altering antigen-receptor responsiveness.
    Wencker M; Turchinovich G; Di Marco Barros R; Deban L; Jandke A; Cope A; Hayday AC
    Nat Immunol; 2014 Jan; 15(1):80-7. PubMed ID: 24241693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF-Derived CD4
    Joshi C; Sivaprakasam K; Christley S; Ireland S; Rivas J; Zhang W; Sader D; Logan R; Lambracht-Washington D; Rosenberg R; Cullum M; Hitt B; Li QZ; Barber R; Greenberg B; Cowell L; Zhang R; Stowe A; Huebinger R; Kelley B; Monson N
    Neurol Neuroimmunol Neuroinflamm; 2022 Jan; 9(1):. PubMed ID: 34848502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.